Shares of Aurora Cannabis Inc. (NYSE:ACB) gained 8.65% to $8.04 on Thursday. The share price is trading in a range of 7.50 – 8.34 (Price in Dollars).
The stock exchanged hands 67.58M shares versus average trading capacity of 17.46M shares, while its shares’ total market worth is $7.76B. Aurora Cannabis Inc. (NYSE:ACB) shares were trading -35.81% below from the 52-week high price mark of $12.52 and +106.16% above from the 52-week price bottom of $4.05.
The company employs N/A people, over the last 12 months has generated revenue of $0.00 and has a net income of $0.00.
The company’s EPS growth in prior 5 years was 0.22%. In the liquidity ratio analysis; current ratio was 0.00 while debt to equity ratio was 0.00.
Canadian cannabis producer Aurora Cannabis Inc (NYSE: ACB) announced Monday that Health Canada has granted its extraction technology partner Radient Technologies Inc (OTC: RDDTF) a standard processing license.
Radient identified a process to extract cannabis and hemp at large-scale volumes without risking the quality of the plant, according to Aurora. The technology, Microwave Assisted Processing, uses microwaves as an energy source to localize the heating of moisture found in natural materials.
A CBD Strategy
Aurora said it became aware of Radient’s technology and its potential to disrupt the market in 2016.
After aligning with Radient, Aurora expanded its efforts with a majority acquisition of Hempco Food and Fiber, as well as Europe’s largest organic hemp product producer, AgroPro. Aurora said its strategy is intended to allow the company to mass-produce CBD extracted oils for the development of high-margin products for the wellness market.
Radient Technologies CEO Denis Taschuk spoke of the importance of having Aurora as a partner in Tuesday’s announcement.
“Our partnership with Aurora has been instrumental these past two years toward achieving this milestone,” the CEO said. “We look forward to executing on our partnership with Aurora on a global scale.”
Radient now plans to scale its operations to include two additional facilities in Edmonton, Taschuk said.
Cleiren Joins Radient Board
Aurora also announced Monday that Aurora COO Allan Cleiren was appointed to Radient’s board. In the same announcement, Cleiren is credited with assisting Radient in obtaining its standard processor license.
In addition to working with Radient, Cleiren sits on the board of Hempco as he plays a pivotal role in integrating Agropro’s operations with Aurora’s CBD endeavors.
Radient’s over-the-counter shares were trading up 34.63 percent to 85 cents at the time of publication Monday, while Aurora shares were up 10.81 percent at $8.20.
Aurora Cannabis institutional ownership is held at 6.46% while insider ownership was 3.09%. Its EPS was $0.22 while outstanding shares of the company were 965.11 million. The Company’s Net profit margin was 0.00% while gross profit margin was 0.00%. ACB last month stock price volatility remained 7.29%.
The stock is now trading at a distance of 25.11% from 20-day simple moving average. The company’s price sits 36.25% above from its 50-day moving average of $5.96 and 21.93% far from the stock’s 200-day moving average which is $6.74.
Aurora Cannabis Inc. (NYSE:ACB) currently has a PEG ratio of 0.00 where as its P/E ratio is 37.22. The company’s price to sales ratio for trailing twelve months is 0.00 and price to book ratio for most recent quarter is 2.34, whereas price to cash per share for the most recent quarter is 0.00. Aurora Cannabis Inc. (NYSE:ACB)’s price to free cash flow for trailing twelve months is 0.00. Its quick ratio for most recent quarter is 0.00 along with current ratio for most recent quarter of 0.00. Total debt to equity ratio of the company for most recent quarter is 0.00 whereas long term debt to equity ratio for most recent quarter is 0.00. Aurora Cannabis Inc. (NYSE:ACB) has a Return on Assets of 0.00%. The company currently has a Return on Equity of 0.00% and Return on Investment of 0.00%.